Heather Hamptons

Not sure if this has been posted yet.

------------------------------------------------------------------------------

NEW YORK (Sept. 30) - The arthritis drug Vioxx, used by two million people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the maker, Merck & Co., said Thursday.

''Patients who are currently taking Vioxx should contact their health care providers to discuss discontinuing use of Vioxx and possible alternative treatments,'' Merck said.

The company, whose stock price plunged on the news, said it was withdrawing the drug following a review of data from a three-year colon cancer trial.

''In this study, there was an increased relative risk for confirmed cardiovascular events, such as heart attack and stroke, beginning after 18 months of treatment in the patients taking Vioxx compared to those taking placebo,'' Merck said in a press release.

The Food and Drug Administration said it would closely watch drugs in the same class as Vioxx, which would include Pfizer Inc.'s Celebrex, for signs of risk.

Worldwide sales of Vioxx totaled $2.55 billion last year. Since the introduction of the drug in 1999, 91 million Vioxx prescriptions have been written in the United States alone. The drug is sold in some countries under the name Ceoxx.


Resources


Stock Quote: MRK
Discuss: Post | Chat
Search: Vioxx



Merck is already gearing up for lawsuits over Vioxx. ''We have substantial defenses in these cases and will defend them vigorously,'' said Kenneth Frazier, Merck's general counsel.

The setback comes at a particularly bad time for Merck, which is struggling with anemic sales and profit growth, and is slated to lose patent protection on its biggest selling drug, cholesterol fighter Zocor, in 2006.

Vioxx was one of the company's ''five key drivers for future growth,'' said Sena Lund, an analyst at Cathay Financial.



91 Million
Number of Vioxx prescriptions written in the United States since drug was introduced in 1999

2 Million
People worldwide currently taking Vioxx, according to Merck

$2.55 Billion
Sales of Vioxx worldwide last year

80
Number of countries where Vioxx has been marketed

27 Percent
Figure by which Merck shares plummeted on news of the drug maker's problems




Merck shares fell 27 percent in early trading on the New York Stock Exchange, wiping out more than $25 billion of market value. Shares of Pfizer, which sells two rival arthritis drugs, edged higher.

Merck Chairman and Chief Executive Raymond Gilmartin said he had no intention of resigning.

Vioxx sales have been flat in recent years amid safety concerns. Clinical trial data have shown the drug increased the incidence of blood clots tied to strokes and heart attacks.

A recent study by the Food and Drug Administration suggested patients taking Vioxx faced a 50 percent greater risk of heart attacks and sudden cardiac death than those taking Pfizer's Celebrex arthritis treatment.

Sales of the Pfizer arthritis drugs Celebrex and Bextra have steadily grown as doctors have turned to those drugs, which have not been linked to heart attack and stroke.

The colon cancer trial was designed to evaluate the effectiveness of the standard 25-milligram Vioxx dose in preventing recurrence of colon polyps. Such polyps sometimes become cancerous.

Vioxx was used in the colon cancer trial because some researchers theorize that inflammation, present in arthritis, may be linked to colon cancer.




Merck said the heart attacks and strokes were not spotted during the first 18 months of the trial but became apparent later.

''Given the availability of alternative therapies, and the questions raised by the data, we concluded that a voluntary withdrawal (of Vioxx) is the responsible course to take,'' Merck chief Gilmartin said.

Merck said it remains comfortable with its earnings forecast for full-year 2004 of $3.11 to $3.17 per share.

It expects the recall to drag down earnings by 50 cents to 60 cents per share because of lost sales and costs of the recall, but is uncertain when those costs will be recorded.

__________________
SIG TOO BIG! Maximum 120x60 button and no more than 3 text lines of DEFAULT SIZE and COLOR. Unless your sig is for a GFY top banner sponsor, then you may use a 624x80 instead of a 120x60.

GiantGnome

Yes I am and my wife just told me about that.

__________________
NOOOOOOOOOOOOOOOOOOOOOOO-Darth Vader

axelcat

that sucks, they should of known this a long time ago

sacX

From what I've heard about this, it's not something you should be particularly worried (especially if you're reasonable young) about if you've taken vioxx.

The problem is aspirin is very good at reducing heart attacks, but if you are taking vioxx you can not also take aspirin.

So a lot more people ended up having heart attacks because they were NOT on aspirin, as opposed to effects of the vioxx.

Trixie Racer

I saw that this morning too. I just finished my week prescription. Oh well..

__________________
Make a Red Cross Donation!

Heather Hamptons

It kinda freaked me out. My fiance is taking it for his hand. Just bought another full bottle.

He's 6'5" 290 so obviously he gets a large dose.

__________________
SIG TOO BIG! Maximum 120x60 button and no more than 3 text lines of DEFAULT SIZE and COLOR. Unless your sig is for a GFY top banner sponsor, then you may use a 624x80 instead of a 120x60.

Candice

Wow, good thread, I have some relatives to send this information to. Thanks for the heads up, I don't watch TV, so I don't keep up with ads, commercials, etc. Good ol' GFY comes in handy at times!

xoxo,

C~

__________________
You judge me for being different, I laugh because you are all the same!

Heather Hamptons

My pleasure..
It's a common medicine that prescribed very often. Figured atleast a few people here could use the 411

__________________
SIG TOO BIG! Maximum 120x60 button and no more than 3 text lines of DEFAULT SIZE and COLOR. Unless your sig is for a GFY top banner sponsor, then you may use a 624x80 instead of a 120x60.